Search results
3 de jul. de 2024 · In 2018, the two scientists, James Allison and Tasuku Honjo, were credited with the “discovery of cancer therapy by inhibition of negative immune regulation” and awarded the Nobel prize in Physiology or Medicine.
9 de jul. de 2024 · years after James P. Allison's ground-breaking discovery of the TCR in 1982 [2]. In 1985, with further characterization of TCRγ in mice [3-5], separate groups demonstrated the existence of TCRγ in humans. One group pinpointed the presence of TCRγ on the short arm of chromosome 7,
1 de jul. de 2024 · The James P. Allison Institute at The University of Texas MD Anderson Cancer Center announced the appointment of its newest members, Susan Bullman, and Xi Chen, to further the institute’s ongoing work of impactful immunobiology research.
1 de jul. de 2024 · Dr. James P. Allison biography. Dr. James P. Allison is the Founder at Jounce Therapeutics Inc.
8 de jul. de 2024 · what a line up! 2018 Nobel Prize winner James P. Allison, Philip D. Greenberg, M.D and Robert H. Vonderheide, Ph.D., and a fireside chat featured insights and opinions from Bristol-Myers Squibb's Vice President, Head of U.S. Oncology
13 de jul. de 2024 · James P. Allison – Professor of Molecular and Cell Biology, Director of the Cancer Research Laboratory (1985–2004); Nobel laureate (2018, Physiology or Medicine) for the "discovery of cancer therapy by inhibition of negative immune regulation"
28 de jun. de 2024 · Comparison of the prognostic value of measures of the tumor inflammatory cell infiltrate and tumor-associated stroma in patients with primary operable colorectal cancer. J. H. Park, D. C. McMillan, J. Edwards, P. G. Horgan & C. S. D. Roxburgh. Article: e1098801.
